The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.本揭示案係關於用於治療C型肝炎病毒(HCV)感染之化合物、組合物及方法。亦揭示含有該等化合物之醫藥組合物及使用該等化合物來治療HCV感染之方法。